We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+11.96%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$109B
AUM Growth
+$5.89B
(+5.7%)
Cap. Flow
-$3.72B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
32.97%
Holding
343
New
8
Increased
53
Reduced
229
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$164M |
| 2 |
Fidelity National Information Services
FIS
|
+$140M |
| 3 |
Intel
INTC
|
+$124M |
| 4 |
GSK
GSK
|
+$111M |
| 5 |
Mobileye
MBLY
|
+$62.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$753M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
+$370M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$197M |
| 5 |
Morgan Stanley
MS
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.81% |
| 2 | Technology | 27.17% |
| 3 | Industrials | 11.89% |
| 4 | Financials | 8.82% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
MGM Resorts International
MGM
$11.2B
| $28.2M | 0.03% |
841,070
-5,540
| -0.7% | -$192K |
|
202
Cameco
CCJ
$42.4B
| $28.1M | 0.03% |
1,241,500
+23,700
| +2% | +$557K |
|
203
Zoom
ZM
$30.6B
| $27.4M | 0.03% |
404,950
+241,900
| +148% | +$18.4M |
|
204
Ollie's Bargain Outlet
OLLI
$4.94B
| $26.9M | 0.02% |
573,790
-36,610
| -6% | -$1.97M |
|
205
XPO
XPO
$23.7B
| $26.2M | 0.02% |
787,500
-88,333
| -10% | -$2.98M |
|
206
Kirby Corp
KEX
$6.93B
| $26M | 0.02% |
403,500
-13,200
| -3% | -$881K |
|
207
Brinker International
EAT
$9.66B
| $24.1M | 0.02% |
756,500
-39,100
| -5% | -$1.23M |
|
208
Glaukos
GKOS
$10.6B
| $24M | 0.02% |
550,480
+12,590
| +2% | +$621K |
|
|
EXAS
209
DELISTED
Exact Sciences
EXAS
| $23.7M | 0.02% |
479,300
| – | – |
|
|
AXON
210
Axon Enterprise
AXON
$46.4B
| $23.4M | 0.02% |
141,000
-54,200
| -28% | -$8.57M |
|
211
OSI Systems
OSIS
$3.89B
| $23.3M | 0.02% |
293,310
-10,790
| -4% | -$878K |
|
212
Zentalis Pharmaceuticals
ZNTL
$302M
| $22.8M | 0.02% |
1,130,170
-49,530
| -4% | -$1.07M |
|
213
Tyson Foods
TSN
$20.4B
| $22.1M | 0.02% |
355,300
-1,500
| -0.4% | -$97.6K |
|
214
Norfolk Southern
NSC
$75.1B
| $21.6M | 0.02% |
87,700
-6,000
| -6% | -$1.42M |
|
215
GFL Environmental
GFL
$14.9B
| $21.4M | 0.02% |
+731,200
| New | +$19.8M |
|
216
CrowdStrike
CRWD
$218B
| $21.3M | 0.02% |
810,340
-49,200
| -6% | -$1.68M |
|
217
Matsons
MATX
$6.18B
| $20.8M | 0.02% |
332,992
-2,300
| -0.7% | -$152K |
|
218
TechnipFMC
FTI
$27.3B
| $20.8M | 0.02% |
1,703,100
+24,600
| +1% | +$275K |
|
219
Unity
U
$18.9B
| $19.9M | 0.02% |
695,617
+101,478
| +17% | +$3.18M |
|
220
Perimeter Solutions
PRM
$5.77B
| $18.7M | 0.02% |
2,045,011
-185,690
| -8% | -$1.63M |
|
221
indie Semiconductor
INDI
$854M
| $17.8M | 0.02% |
3,060,900
+245,000
| +9% | +$1.81M |
|
222
Dell
DELL
$293B
| $17.8M | 0.02% |
443,370
-13,185
| -3% | -$521K |
|
223
IMAX
IMAX
$2.66B
| $17.7M | 0.02% |
1,205,500
+187,100
| +18% | +$2.73M |
|
|
DOOR
224
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $17.4M | 0.02% |
216,200
+2,200
| +1% | +$163K |
|
225
Waters Corp
WAT
$39.9B
| $17.4M | 0.02% |
50,694
-500
| -1% | -$158K |
|
Similar funds
VAM
Primecap Management's Q4 2022 Portfolio in Review
As of Q4 2022, Primecap Management held 343 positions worth $109B, up 5.7% from $103B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Primecap Management withdrew a net $3.72B in Q4 2022, closing 9 positions and reducing 229 holdings. Its most notable exit was Abiomed Inc, an estimated $370M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 33% a quarter earlier, followed by Technology and Industrials.
Against the trend, Primecap Management opened a new position in Mobileye worth $72.3M.
- Primecap Management's largest Q4 2022 buy was Mobileye: 2,061,470 shares worth $72.3M.
- Primecap Management added most to Splunk Inc in Q4 2022, an estimated $164M increase.
- Primecap Management's biggest Q4 2022 reduction was Eli Lilly, cutting an estimated $753M.
- Primecap Management fully exited Abiomed Inc in Q4 2022, selling an estimated $370M.
- Primecap Management's ten largest holdings make up 33% of its $109B portfolio in Q4 2022.
- Primecap Management opened 8 new positions and closed 9 in Q4 2022.
- Primecap Management's portfolio value rose 5.7% quarter-over-quarter to $109B.
Based on Primecap Management's 13F filing for Q4 2022, filed 13 Feb 2023.